indicate that human enzymes belonging to the RNase A family Pancreatic-type RNases are considered to have cytotoxic can be used as toxins in the construction of immunotoxins potential due to their ability to degrade RNA molecules , although human RNases as well as RNase when they enter the cytosol. However, most of these RNases A are not in themselves cytotoxic. In humans, six members show little cytotoxicity because cells have no active uptake of the extracellular RNase A family are known. These RNases mechanism for these RNases and because the ubiquitous are distributed in various tissues (Rosenberg and Dyer, 1996 ; cytoplasmic RNase inhibitor is considered to play a Futami et al., 1997) and possess various biological activities protective role against the endocytotic leak of RNases from in addition to digestive activity (Sorrentino, 1998) . We have the outside of cells. To study the cytotoxic potential of reported the expression of recombinant human RNase 1 which RNase toward malignant cells targeting growth factor was cloned from human pancreas (Futami et al., 1995) .
receptors, the C-terminus of human RNase 1 was fused to
We have also shown that recombinant RNase 1 chemically the N-terminus of human basic fibroblast growth factor conjugated and/or genetically fused to EGF is effective as an (bFGF). This RNase-FGF fused protein effectively inhibited immunotoxin against EGFR-overexpressing human squamous the growth of mouse melanoma cell line B16/BL6 with high carcinoma cells (Jinno et al., 1996a; Psarras et al., 1998) .
levels of cell surface FGF receptor. This effect appeared to
Other members of human RNases, such as RNase 2 (eosinophilresult from prolongation of the overall cell cycle rather derived neurotoxin, EDN) and RNase 5 (angiogenin), have than the killing of cells or specific arrest in a particular been successfully used as toxic domains of immunotoxins phase of the cell cycle. Thus, human RNase 1 fused to a (Newton et al., 1994 (Newton et al., , 1996 Zewe et al., 1997) . ligand of cell surface molecules, such as the FGF receptor, Basic fibroblast growth factor (bFGF) can regulate a number is shown to be an effective candidate for a selective cell of distinct biological activities in vivo and in vitro (Basilico targeting agent with low toxic effects on normal cell types.
and Moscatelli, 1992) and is considered to be involved in the Keywords: cytotoxic/FGF/immunotoxin/RNase/targeting growth of a variety of neoplastic cell lines derived from melanomas (Halaban et al., 1988) , breast cancer (PenaultLlorca et al., 1995) , astronoma (Zagzag et al., 1990) and ovarian carcinoma (Crickard et al., 1994) , and in the proliferaIntroduction tion of mesangial cells in the glomerular disease (Floege Improvement of cytotoxic agents specific to cancer cells or et al., 1993) . Since overexpression of FGF receptors possibly other cells causing proliferative diseases is one of the goals correlate with the malignancy of tumors and bFGF is proposed of targeting chemotherapy. Such cells often express surface to support autocrine growth of melanoma cells (Ahmed et al., receptors or other molecules distinguishing them from the 1997), the receptors are potential targets for melanoma therapy surrounding normal cells. In this regard, many immunotoxins . In fact, the chemical conjugates or fusion have been developed which exploit this difference. Immunoprotein between bFGF and saporin, a ribosome-inactivating toxins are defined as proteins containing an antibody (or a protein isolated from the plant Saponaria officinalis, have been ligand) and a toxin (Lappi and Baird, 1990; Kreitman and developed to show the growth inhibitory effect on the cells Pastan, 1998). The moiety of antibody or ligand specific for a expressing FGF receptors (Lappi et al., 1991 (Lappi et al., , 1994 ; Beith cell surface molecule delivers the toxin to the target cells. et al., 1992) . Plant and bacterial toxins have been the most intensively
In this paper, we designed a fused protein between human studied moieties. These toxins are enzymes that catalytically RNase 1 and human bFGF as humanized immunotoxins. The abolish protein synthesis when they translocate into the cytosol.
fused proteins showed cell type-specific growth inhibition Although some of these immunotoxins are promising, clinical against malignant cells bearing FGF receptors; however, the applications are still limited due to their inherent toxicities to effect was cytostatic rather than cytotoxic. normal cells as well as their immunogenicity. Distinct targeting specificity and humanized design of immunotoxins are needed Materials and methods to overcome these difficulties. Materials It has been shown that upon microinjection of Xenopus oocytes, bovine RNase A inhibited protein synthesis at Recombinant human RNase 1, des.1-7RNase 1 and human bFGF [147 amino acid form] were purified from Escherichia concentrations comparable to plant and bacterial toxins . Therefore, RNases are considered to be coli as described previously (Futami et al., 1995 ; Iwane chloramphenicol (10 µg/ml) overnight at 37°C. The culture was then diluted 50-fold with LB medium and further incubated at 37°C in an incubator shaker. When an A 600 of 0.6 was reached, isopropyl 1-thio-β-D-galactopyranoside (IPTG) was added to a final concentration of 0.4 mM, and the growth was continued for a further 3 h at 37°C. Cells were harvested by centrifugation and washed once with physiological salt solution, and stored at -80°C until they were used. Frozen cells obtained from a 1 l culture were thawed at 37°C and suspended in 100 ml lysis buffer (10 mM TrisHCl, pH 7.5, containing 10% sucrose and 0.2 M NaCl). The suspension was then homogenized (LK-21; Yamato, Japan) followed by freeze-thaw for complete lysis. The insoluble fraction was collected by centrifugation, resuspended in 10 ml lysis buffer, sonicated on ice for 3 min, and then centrifuged at 10 000 g for 10 min. The pellet was washed with 50 ml of 0.5% Triton X-100 containing 1 mM EDTA and 0.2 M NaCl, and then centrifuged at 10 000 g for 10 min. The resulting pellet was dissolved in 10 ml of 0.1 M Tris-HCl, pH 8.5, containing 6 M guanidinium-HCl (GdmCl), and then the fused proteins were reduced with 0.1 M 2-mercaptoethanol at 37°C for 90 min under a nitrogen atmosphere. The solution was et al., 1987) . Single-stranded polyribonucleotide, poly(C), a NaCl. The eluted fractions were pooled and stored at -80°C preferable substrate for human RNase 1, was purchased from until use. Usually, the protein solution thus obtained was Seikagaku Kogyo (Japan).
appropriately diluted and used for biological assay. If necessary, Cell culture fused proteins were desalted by C 4 reverse phase HPLC (Ultron 300 C 4 , 45ϫ150 mm, Chromatopacking Center, Japan) Mouse metastatic melanoma B16/BL6 cells (Poste et al., before analysis. 1980) were grown in RPMI 1640 (Nissui, Japan) medium Amino acid compositions of fused proteins were determined supplemented with 10% fetal bovine serum (FBS). Mouse by Hitachi L8800 amino acid analyzer after hydrolysis of BALB/c 3T3 A31 cells were grown in purified samples, and N-terminal sequences of fused proteins Dulbecco's modified Eagle's medium (DMEM; Nissui, Japan)
were determined with an Applied Biosystems Procise™ 491 supplemented with 10% calf serum (CS). All media contained protein sequencer. 70 µg/ml kanamycin as antibiotic and each cell line was maintained in a humidified atmosphere consisting of 5% CO 2
Assay of RNase activity in air at 37°C.
RNase activity using poly(C) was measured by a spectroPlasmid construction of RNase-FGF fused proteins photomeric procedure (Sorrentino and Libonati, 1994) with some modification. Briefly, 495 µl substrate solution [0.1 M Human RNase 1 or des.1-7RNase 1 cDNA (Seno et al., 1994;  HEPES-NaOH, pH 7.5, containing 0.1 M NaCl, 0.01% bovine Futami et al., 1995) was ligated to the 5Ј-end of the cDNA serum albumin and 0.1 mM (in phosphodiester groups) poly(C)] encoding human bFGF ( Figure 1B ). Briefly, HindIII restriction was pre-incubated at 25°C. The reaction was started by adding sites were introduced into the 3Ј-end of human RNase 1 or 5 µl of the appropriate amount of each RNase or RNase-FGF des.1-7RNase 1 cDNA and the 5Ј-end of human bFGF cDNA fused protein and the increase in absorbance at 260 nm due by site-directed mutagenesis. Two cDNAs coding for RNaseto the transphosphorylation reaction catalyzed by RNase was FGF fused proteins were inserted into the T7 expression vector continuously monitored with a spectrophotometer (Hitachi pET-3a (Studier and Moffat, 1986) .
U-2000, Japan) at 25°C.
Expression and purification of RNase-FGF fused proteins
Heparin affinity HPLC For the expression of the two fused proteins, RNase 1 and bFGF (RNF) and des.1-7RNase 1 and bFGF (des.1-7RNF), Purified protein solution was appropriately diluted with buffer A (described above) to reduce the NaCl concentration E.coli BL21(DE3)pLysS (Studier and Moffat, 1986 ) and E.coli MM294(DE3)pLysS (Watanabe et al., 1990) were transformed to 0.2 M, then applied to the heparin affinity HPLC column (Shodex AF pak HR-894, 8ϫ50mm, Showa-denko, Japan). with the plasmids described above. Each transformant was grown in LB medium containing ampicillin (50 µg/ml) and
The elution was performed using a linear gradient of NaCl concentration from 0 to 2 M in 10 mM Tris-HCl, pH 7.5, for with the fresh one containing the same sample. On day 7, colonies were fixed with 10% formalin and stained with 60 min at a flow rate of 0.5 ml/min. crystal violet.
Induction of tyrosine phosphorylation
Tyrosine phosphorylation induced by RNase-FGF fused proResults teins were detected by an anti-phosphotyrosine antibody.
Design of immunotoxins based on human RNase 1 and bFGF Briefly, equal numbers of mouse BALB/c 3T3 A31 cells were plated onto 60-mm dishes and when Although the three-dimensional structure of human RNase 1 confluence was reached, the cells were washed and starved has not been determined, its structure is probably very similar in DMEM containing 0.2% CS for 2 days, and then a 1 nM to that of bovine RNase A, because all members of the RNase concentration of bFGF, RNF, des.1-7RNF, RNase 1 or 10% A family of proteins in which the three-dimensional structures CS was added. After 5 min, cells were washed once with icehave been determined, so far, are known to have common cold 20 mM HEPES-NaOH, pH 7.4, containing 150 mM folds (Tilton et al., 1992; Acharya et al., 1994 ; Mosimann NaCl, and harvested into 50 µl SDS-sample buffer. Samples et al., 1994 Samples et al., , 1996 Terzyan et al., 1999) . Both N-and Cwere boiled for 3 min and 30 µl of the samples were terminal regions are close to the active site cleft in RNase A electrophoresed on a 7.5% polyacrylamide gel, and then the (Fontecilla-Camps et al., 1994) . In contrast, RNase 1 is longer proteins were transferred onto a nitrocellulose filter (0.45 µm;
by four amino acid residues at the C-terminus and is only ADVANTEC, Japan). The blot was then blocked with 1% moderately less active than RNase A (Seno et al., 1994) . bovine serum albumin in TBS-T (10 mM Tris-HCl, pH 7.5, Furthermore, we have shown that truncation of seven amino containing 150 mM NaCl and 0.05% Tween 20) at 4°C, and acid residues in the N-terminal sequence of RNase 1 resulted then incubated with the primary antibody (mouse monoclonal in not only a much reduced activity, but also in a more anti-phosphotyrosine antibody clone PY20; ICN, USA) diluted pronounced reduction in the affinity to human placental RNase to 1:1000 in TBS-T for 1 h at room temperature. After three inhibitor (Futami et al., 1995) . As for the bFGF molecule, the 20-min washes with TBS-T, the secondary antibody (goat anti-C-terminal structure significantly contributes to its affinity for mouse IgG conjugated to alkaline phosphatase; Promega, USA)
heparin , while its N-terminal portion is diluted to 1:7500 in TBS-T was added and incubated for 1 h. flexible and not essential for its biological activity (Seno et al., The blot was then washed thoroughly and the purple color 1989; Moy et al., 1996) . Thus, we designed two fused proteins was developed in the presence of 165 µg/ml 5-bromo-4-as immunotoxins based on human RNase 1 and human bFGF, chloro-3-indolyl-phospate and 330 µg/ml nitroblue tetrazolium as shown in Figure 1B , in which RNF is a protein fused (Promega, USA) in 100 mM Tris-HCl, pH 9.5, 100 mM NaCl between the C-terminus (Thr128→Ser) of RNase 1 and the and 5 mM MgCl 2 .
N-terminus (Leu9) of the 147-amino acid form of human bFGF, and des.1-7RNF is a 7-N-terminal-residue truncated Assays for growth inhibitory effect of RNase-FGF fused RNF. Figure 1A shows a schematic three-dimensional structure protein of RNF in which the full length of RNase A (Tilton et al., The cell numbers were estimated with 3-(4,5-dimethyl thiazol-1992) and residues 9-155 of bFGF (Moy et al., 1996) are 2-yl)-2,5-di-phenyltetrazolium bromide (MTT) as described linked with an arbitrary 4-residue linker. previously (Tada et al., 1986) . Exponentially growing mouse Production, refolding, purification and characterization of metastatic melanoma B16/BL6 cells (Poste et al., 1980) were RNase-FGF fused proteins seeded into 96-well plates (500 cells/well; Falcon, USA) in RPMI 1640 medium supplemented with 3% FCS and incubated
The fused proteins, RNF and des.1-7RNF, were expressed in E.coli strains MM294(DE3)pLysS and BL21(DE3)pLysS. Both for 12 h at 37°C, prior to addition of the reagents. The cells were then exposed to various concentrations of reagents for 2 strains gave almost the same results. In the case of RNF expression (Figure 2 ), induction with IPTG led to the days. The percent of cell growth was calculated in triplicate, with the cells grown without the reagents as the control. The accumulation of recombinant proteins up to about 50% of total cellular protein ( Figure 2 , lane 2). After lysis, the fused effects of RNF on several human carcinoma-derived cells were assessed by the same procedure, except for estimation of cell proteins were recovered as inclusion bodies, which were exhaustively washed to give a protein purity of about 90% numbers with sulforhodamine B (Yamori et al., 1997) instead of MTT.
( Figure 2, lane 3) . The proteins were dissolved in 6 M GdmCl, reduced with Cell cycle analysis 2-mercaptoethanol, rapidly diluted in redox buffer, pH 8.5, The effect of RNase-FGF on the cell cycle of B16/BL6 cells containing 0.4 M GdmCl, and kept at 4°C overnight for was analyzed by flow cytometry. B16/BL6 cells (1ϫ10 6 ) were refolding by SH-SS interchange. Utilizing the specific affinity plated into 60-mm dishes in medium and treated with or of bFGF towards heparin (Seno et al., 1988) , refolded fused without 5 µM RNF. After 24 h, cells were harvested and proteins were purified by heparin affinity chromatography with nuclear DNA was stained with propidium iodide as described the stepwise elution of NaCl. As shown in Figure 2 , lanes 4 by Noguchi (1991). The cellular fluorescence was measured and 5, both RNF and des.1-7RNF thus purified gave almost with the FACStation (Becton Dickinson, UK).
single bands on SDS-PAGE. Analysis by reverse phase HPLC Colony formation assay and cation-exchange HPLC also showed that they were composed of almost single species, respectively (data not shown). The effects of RNase-FGF fused proteins on the proliferation of B16/BL6 cells were assessed by the number and sizes of
The yields of the fused proteins from a 1 l culture were both about 22 mg. colonies formed from 500 cells initially plated in a 35-mm dish. The cells are plated in RPMI 1640 medium supplemented
The amino acid composition and the N-terminal sequence of each RNF and des.1-7RNF were both confirmed to be with 3% FCS. After 5 h, each sample was added at a concentration of 2.5 µM. On day 5, the medium was replaced coincident with the design. An N-terminal Met residue of each fused protein takes the correct conformation to bind FGF receptors (Figure 3) .
The results described above indicate that both the RNase cell expresses both bFGF and high-affinity FGF receptor (Blanckaert et al., 1993) , we employed this cell line expressing FGF receptor at high levels as a model target of the RNasedes.1-7RNF was completely processed out as expected. The numbers of SH groups per molecule determined by colorimetric FGF fused proteins. Both of the RNase-FGF fused proteins showed similar dose-dependent growth inhibitory effects on analysis using 5,5Ј-dithiobis(2-nitrobenzoic acid) (Ellman, 1959) were found to be 4.18 for RNF. These values are B16/BL6 cells in the micromolar range (Figure 4 ). However, these growth inhibitory effects were not observed when cells consistent with the fact that the RNase domain should have no SH group and four SS groups, while the FGF domain were treated with an equimolar mixture of RNase 1 and bFGF. Cytotoxic assays for human carcinoma-derived cell lines should have four SH groups and no SS group. Table I shows the RNase activity of the fused proteins were also performed by systematic screening by the Cancer Chemotherapy Center, Japan. Table II lists seven sensitive cell and their parent RNases towards poly(C). Both RNF and des.1-7RNF retained activity and were 8-15-fold less active lines against RNF out of 38 kinds of cell lines employed in this screening. Cell lines expressing FGF receptors (MDAthan RNase 1 and des.1-7RNase 1, respectively, suggesting that the RNase domains in these fused proteins are properly MB-231, MCF-7 and HT-29) were inhibited in their growth in the micromolar range. In contrast, no growth inhibition was folded and their RNase activity decreased due to the introduction of the FGF domain at the C-terminus. Des.1-7RNF was observed on the human epidermoid carcinoma cell line A431, which does not express a FGF receptor, suggesting that RNase-20-fold less active than RNF.
Analysis by heparin affinity HPLC under the conditions of FGF fused proteins are specifically effective against cells expressing FGF receptors (Table II) . the linear gradient elution of NaCl (0-2 M) at pH 7.5 indicated that RNF and des.1-7RNF were eluted at 1.65 and
We conducted the following experiment to characterize the effect of the growth inhibitory effect on B16/BL6 cells 1.60 M NaCl, while bFGF and RNase 1 were eluted at 1.30 and 0.62 M NaCl, respectively. These results suggest that the by the RNase-FGF fused protein. First, the effect was assessed by colony formation at different concentrations of the RNase-FGF domain is also properly folded in each fused protein to maintain the high affinity towards heparin.
FGF fused protein. The MTT assay in Figure 4 shows a 50-70% inhibition of cell growth at a protein concentration of The potential of the fused proteins to induce tyrosine phosphorylation of some cellular proteins including the 2.5 µM. Although sparsely plated B16/BL6 cells formed 200Ϯ30 colonies in the presence or absence of fused proteins, major substrate of p92-95 (FGF receptor substrate 2; FRS2), which is specific to the stimulation of the FGF-receptor the average size of each colony decreased to about 60% when treated with the fused proteins, while an equimolar mixture of mediated Ras/MAPK signaling pathway (Kouhara et al., 1997) , was assessed. RNF and des.1-7RNF induced the tyrosine FGF and RNase did not show any inhibitory effect on the formation of colonies ( Figure 5 ). Second, we analyzed the cell phosphorylation of bFGF, indicating that the FGF domain in cycle distribution of B16/BL6 on growing cells and growth suppressed cells by RNF. In spite of the cells treated with 5 µM RNF showing an apparent suppression of growth, the DNA frequency histogram is quite similar to that of growing cells, suggesting that the growth inhibitory effect was not related to the arresting of the cell cycle at any particular stage ( Figure 6 ). Thus, we have successfully demonstrated that RNase-FGF fused proteins suppress cell growth in a FGF receptordependent manner with a prolonged overall cell cycle. many of which are expressed in solid tumors, and several of which were shown to be targeted using FGF as a ligand (Lappi, 1995) . Since the FGF molecule shows a specific FGF receptor. On the other hand, human pancreatic RNase 1 has the potential to be engineered into a toxin. The aim of affinity to a wide range of FGF receptor proteins, FGF would be a better ligand than antibodies specific to single species of this study was the preparation of agents targeting FGF receptors overexpressed in tumors by designing a fusion protein between others have not yet been examined in this respect. We studied the relationship between GI 50 s by RNF and FGF receptor human RNase 1 and human bFGF.
We designed two RNase-FGF fusion proteins, RNF and levels in MDA-MB-231 and MCF-7, which suggested the existence of two possible pathways for internalization of des.1-7RNF, in which the C-terminal Ser128 of human RNase 1 or des.1-7RNase 1 was fused to the Leu9 of human bFGF bFGF: high affinity receptor-mediated and low affinity receptor (heparin-like molecule)-mediated, also described previously (Figure 1 ), which were expressed in E.coli as inclusion bodies. Since the expression of RNase activity would inhibit host cell (Roghani and Moscatelli, 1992) . These results again suggest that the cytostatic effect of the RNase-FGF fused proteins is growth, formation of inclusion bodies should be advantageous. In this case, however, the folding into the active conformation specific to the cells overexpressing FGF receptors. Basic FGF has been suggested to be involved in a number becomes a crucial step. Nevertheless, we have obtained good yields of folded RNF (or des.1-7RNF) from inclusion bodies of proliferative diseases and pathogenesis (Baird et al., 1986) , including angiogenesis, which is important in carcinogenesis by SH-SS interchange reaction in redox buffer (about 22 mg from a 1 l culture). One of the critical points to emerge was (Folkman et al., 1989) . Expression of bFGF specific receptors (FGFR1) are also up-regulated in the mesangial proliferative the use of a rather high concentration (0.4 M) of GdmCl in the folding. The presence of 0.4 M salt, such as NaCl, KCl, stage of glomerular failure (Jyo, 1996) . All the cells pathologically associated with these disorders should be potential targets NH 4 Cl or Arg-HCl, also gave good yields of the folded protein. At concentrations below 0.2 M, besides the increase of a bFGF-based growth inhibitor. In the case of the proliferative disorders, such as glomerulonephritis, it may be important in the formation of precipitates, several improperly folded species were obtained. The latter was judged from the to suppress only the proliferation of cells without killing them. The cytostatic nature of RNF or des.1-7RNF may be useful lower affinity on a heparin column and from the elution profile of multiple peaks on a cation-exchange HPLC analysis for the treatment of such bFGF-induced proliferative disorders. Some members of pancreatic-type RNase family, such as (unpublished data). Because highly purified fused protein was efficiently folded into a single species in a salt concentration onconase and bovine seminal dimeric-RNase (BS-RNase), have cytotoxic activity against cancer cells and/or anti-HIV independent manner, an electrostatic interaction between the fused protein and the other materials in the inclusion bodies, activity (Vescia et al., 1980; Wu et al., 1993; Saxena et al., 1996) . Onconase is now in clinical trials for cancer therapy such as nucleic acids, may interfere with the correct folding of the fused proteins (unpublished data). . All investigated mammalian pancreatictype RNases, except for BS-RNase, are known to be severely Folded RNF and des.1-7RNF were purified using a onestep procedure by heparin affinity chromatography. RNF and inhibited by a RNase inhibitor that occurs in the cytoplasm of virtually all mammalian cells (Futami et al., 1997 ; Hofsteenge des.1-7RNF, thus purified, retained well the physicochemical and biological properties originating from RNase, et al., 1998) . Both onconase and BS-RNase have also been reported to weakly interact with RNase inhibitor (Murthy and des.1-7RNase and bFGF. The RNase activity was decreased 8-15-fold (Table I) , probably due to the interdomain steric Sirdeshmukh, 1992; Wu et al., 1993) . Hence, the first mechanism of cytotoxicity of these RNases hindrance rather than incorrect folding, because the stability of each domain against trypsin digestion was similar to those has been explained as follows. Cytotoxic RNases are adsorbed on the cell surface and internalized into cells. Second, they of the unfused proteins, respectively (data not shown).
Both RNF and des.1-7RNF showed dose-dependent growth degrade cellular RNA evading cytosolic RNase inhibitor and inhibit protein synthesis as a result ; Kim inhibitory effects on mouse metastatic melanoma B16/BL6 cells, which are known to overexpress FGF receptors, while et al., 1995) . The mechanism proposed above explains why the cytotoxic potentials of the present RNase-FGF fusion no inhibition was observed in a mixture of RNase 1 and bFGF under the conditions employed (in the presence of 3% serum) proteins are not so high. RNase-FGF fused proteins are considered to be effectively internalized into the cytosol (Figure 4) . Furthermore, the fused proteins did not show any effect on normal fibroblasts such as BALB/c 3T3 (data not through bFGF receptors. Because the cytotoxic potency of an RNase should correlate with the remaining RNase activity in shown). This growth inhibitory effect of RNF and des.1-7RNF was shown to be specific to the cells overexpressing FGF the presence of RNase inhibitor in the cytosol, and because cytosolic RNase inhibitor should severely inhibit the activity receptors, as expected. RNF and des.1-7RNF did not kill B16/ BL6 cells but just slowed down the speed of cell growth of human RNases, the cytotoxic effect of RNF becomes moderate. In this context, des.1-7RNF is an interesting ( Figure 5) . However, the cells were not arrested at any particular stage in the cell cycle when treated with these fused molecule because des.1-7RNase shows a lower affinity than RNase 1 to RNase inhibitor (Futami et al., 1995) . However, proteins ( Figure 6 ). Similar results have been described in the cell growth suppression of onconase, a member of the the growth inhibitory effect of des.1-7RNF was almost identical to that of RNF (Figures 4 and 5) . Because the pancreatic-type RNase family isolated from frog oocytes (Mikulski et al., 1992) . Therefore, a prolonged cell cycle may RNase activity of des.1-7RNF was 20-fold lower than that of RNF, the effect of decreased affinity on the RNase inhibitor be a common property of RNase-mediated growth inhibition. We also examined apoptosis assays on B16/BL6 cells treated may be compensated by the decreased RNase activity. Furthermore, the N-terminally truncated RNase domain may be with 5 µM RNF by electrophoresis of internucleosomal DNA; however, no DNA fragmentation was observed. In this context, unstable against proteolysis in the cytosol. This effect may also compensate for the effect of the decreased affinity to the the RNase-FGF fused proteins prepared here were cytostatic rather than cytotoxic.
RNase inhibitor. If we could internalize more RNF molecules relative to the level of cytosolic RNase inhibitor, a much RNF also showed a growth inhibitory effect on the growth of many carcinoma-derived human cell lines (Table II) . MDAstronger cytotoxicity would result. The balance between the rate of internalization through FGF receptors and the rate of MB-231, HT-29 and MCF-7 are known to overexpress FGF receptors (Peyrat et al., 1991; Murgue et al., 1994) , while the proteolytic degradation may determine the concentration of
